Cerebral autoregulation evidence by synchronized low frequency oscillations in blood pressure and resing-state fMRI by Whittaker, Joseph et al.
 1 
Cerebral autoregulation evidenced by synchronized low frequency 1 
oscillations in blood pressure and resting-state fMRI 2 
Joseph R. Whittaker1*, Ian D. Driver2, Marcello Venzi1, Molly G. Bright3, and 3 
Kevin Murphy1 4 
1. Cardiff University Brain Research Imaging Centre (CUBRIC), School of Physics and Astronomy, 5 
Cardiff University, Cardiff, CF24 4HQ, United Kingdom 6 
2. CUBRIC, School of Psychology, Cardiff University, Cardiff, CF24 4HW, United Kingdom 7 
3. Department of Physical Therapy and Human Movement Sciences, Feinberg School of Medicine, 8 
Northwestern University, Chicago, IL, United States 9 
 10 
*Correspondence 11 
Joseph R. Whittaker 12 
Whittakerj3@cardiff.ac.uk 13 
 14 
Keywords: cerebral autoregulation1, resting-state fMRI2, blood pressure3, cerebral physiology4, LFO5, 15 
BOLD6, CBF7 16 
Abstract 17 
Resting-state functional magnetic resonance imaging (rs-fMRI) is a widely used technique for 18 
mapping the brain’s functional architecture, so delineating the main sources of variance comprising 19 
the signal is crucial. Low frequency oscillations (LFO) that are not of neural origin, but which are 20 
driven by mechanisms related to cerebral autoregulation (CA), are present in the blood-oxygenation-21 
level-dependent (BOLD) signal within the rs-fMRI frequency band. In this study we use a MR 22 
compatible device (Caretaker, Biopac) to obtain a non-invasive estimate of beat-to-beat mean arterial 23 
pressure (MAP) fluctuations concurrently with rs-fMRI at 3T. Healthy adult subjects (n=9; 5 male) 24 
completed two 20-minute rs-fMRI scans. MAP fluctuations were decomposed into different frequency 25 
scales using a discrete wavelet transform, and oscillations at approximately 0.1Hz show a high 26 
degree of spatially structured correlations with matched frequency fMRI fluctuations. On average 27 
across subjects, MAP fluctuations at this scale of the wavelet decomposition explain ~ 2.2% of 28 
matched frequency fMRI signal variance. Additionally, a simultaneous multi-slice multi-echo 29 
acquisition was used to collect 10-minute rs-fMRI at three echo times at 7T in a separate group of 30 
healthy adults (n=5; 5 male). Multiple echo times were used to estimate the R2* decay at every time 31 
point, and MAP was shown to strongly correlate with this signal, which suggests a purely BOLD (i.e. 32 
blood flow related) origin. This study demonstrates that there is a significant component of the BOLD 33 
signal that has a systemic physiological origin, and highlights the fact that not all localized BOLD 34 
signal changes necessarily reflect blood flow supporting local neural activity. Instead, these data show 35 
 2 
that a proportion of BOLD signal fluctuations in rs-fMRI are due to localized control of blood flow that 1 
is independent of local neural activity, most likely reflecting more general systemic autoregulatory 2 
processes. Thus, fMRI is a promising tool for studying flow changes associated with cerebral 3 
autoregulation with high spatial resolution.  4 
 5 
1. Introduction 6 
Functional connectivity in the brain can be assessed with blood-oxygenation-level-dependent (BOLD) 7 
functional magnetic resonance imaging (fMRI). The source of BOLD contrast is the difference in 8 
magnetic susceptibility between oxy- and deoxyhaemoglobin, which has an effect on apparent 9 
transverse relaxation (R2*), and thus imparts sensitivity to blood oxygenation in the MR signal 10 
(Buxton, 2013). Neurovascular coupling (NVC) allows brain activity to be mapped using BOLD fMRI, 11 
because localised increases in cerebral blood flow (CBF), which are proportionally larger than 12 
changes in oxygen metabolism, cause increases in local venous blood oxygenation. An implicit 13 
assumption that predicates BOLD fMRI as a tool for mapping neural activity in the brain is that NVC 14 
related changes in CBF are the predominant source of signal variance. There are however other 15 
mechanisms besides NVC that regulate CBF, such as arterial blood gas concentration, particularly 16 
carbon dioxide (CO2), which is a potent vasodilator with a strong effect on CBF (Battisti-Charbonney 17 
et al., 2011). Furthermore, systemic control of the brain’s blood supply is governed by numerous 18 
homeostatic mechanisms that are broadly defined as cerebral autoregulation (CA) (Willie et al., 2014), 19 
the theoretical process that modulates cerebrovascular resistance to ensure CBF is kept at a 20 
sufficient level in the face of transient changes in systemic haemodynamics (e.g. blood pressure and 21 
cardiac output).  22 
Understanding non-neuronal sources of variance in CBF fluctuations is especially important with 23 
regard to resting state fMRI (rs-fMRI) paradigms for two reasons. Firstly, unlike traditional task based 24 
paradigms for which the timing and duration of evoked BOLD signal changes is known a priori, the 25 
timing of spontaneous neural fluctuations can’t be assumed, meaning non-neuronal effects can’t be 26 
mitigated as they are in task based designs by averaging over trials.  Secondly, the low frequency 27 
range (~ 0.01 – 0.1 Hz) over which functional connectivity is observed overlaps with the spectrum at 28 
which other systemic physiological effects occur (Murphy et al., 2013).  Spontaneous fluctuations in 29 
breathing cause cerebrovascular reactivity (CVR) to CO2 to manifest as low frequency (< 0.05 Hz) 30 
oscillations in the BOLD signal (Wise et al., 2004), and endogenous fluctuations (< 0.1 Hz) in vascular 31 
tone have been reported in various different vascular beds across multiple species (Nilsson and 32 
Aalkjaer, 2003). Recently, low frequency oscillations (LFO) of a systemic origin have been observed 33 
by correlating fMRI signals with functional near-infrared spectroscopy (fNIRS) measures of peripheral 34 
haemodynamics (Tong and Frederick, 2010; Tong et al., 2012). Intriguingly, these systemic LFOs 35 
appear to propagate throughout the brain with spatially structured temporal delays (Erdogan et al., 36 
2016).  37 
 3 
Arterial blood pressure (ABP) is dynamic over multiple time scales, including at a beat-to-beat level, 1 
and so is likely to contribute significantly to fluctuations in CBF.  Transcranial Doppler ultrasound 2 
(TCD) studies have consistently demonstrated how ABP fluctuations modulate cerebral blood flow 3 
velocity (CBFV) in large intracranial arteries (Aaslid et al., 1989; Zhang et al., 1998), and that they 4 
account for a considerable proportion of the total variance, approximately 60% of the total predictive 5 
power of CBFV fluctuations in right middle cerebral artery (MCA) (Mitsis et al., 2004). Evidence for 6 
how blood pressure dynamics affect fMRI fluctuations is scarce, mostly limited to animal studies on 7 
the relationship between transient changes and evoked neural responses (Qiao et al., 2007; Uchida 8 
et al., 2017; Wang et al., 2006). Similar to fMRI, ABP time series have a 1/f power spectrum, but also 9 
show distinct oscillations (~ 0.1 Hz in humans) known as Mayer waves (Mayer, 1876), which are 10 
independent of respiration and tightly coupled to efferent sympathetic nervous activity (Julien, 2006). 11 
Oscillations at this frequency have also been observed in cerebral haemodynamics measured with 12 
fNIRS (Obrig et al., 2000; Yucel et al., 2016) and intraoperative multispectral optical intrinsic signal 13 
imaging (Rayshubskiy et al., 2014).  However, the origins of such signals are unclear, and separating 14 
the effects of ABP fluctuations from vasomotion (which is usually regarded as distinct) on cerebral 15 
haemodynamics is an open challenge.  16 
Nevertheless, the TCD literature provides compelling reason to believe that ABP fluctuations should 17 
contribute to the BOLD fMRI signal. Measurement of the coupling between fluctuations in ABP and 18 
CBFV in intracranial arteries has found widespread use as a clinically useful means of assessing CA 19 
(Panerai, 2008; Panerai et al., 2002; Zhang et al., 1998), and nonlinear modelling estimates that ABP 20 
accounts for 60% of the predictive power of CBFV fluctuations in the middle cerebral artery (Mitsis et 21 
al., 2004). Although TCD has been widely used to assess both CVR and CA in research and clinical 22 
practice (Willie et al., 2011), more recently fMRI has emerged as a powerful tool for mapping CVR 23 
across the brain (Pillai and Mikulis, 2015), and the feasibility of obtaining BOLD fMRI based measures 24 
of CVR from spontaneous CO2 fluctuations has also been demonstrated (Golestani et al., 2016). So 25 
far, these advances in measuring cerebrovascular function with fMRI have not yet extended into the 26 
domain of CA. However, the TCD literature proves that blood pressure related spontaneous CBFV 27 
fluctuations provide an effective means of characterizing CA, which is promising for the development 28 
of an equivalent whole-brain fMRI method. 29 
In this study we explore the relationship between systemic fluctuations in blood pressure and the 30 
resting-state fMRI signal. We measure beat-to-beat blood pressure fluctuations concurrently with 31 
single-echo fMRI at 3T and multi-echo fMRI at 7T, and show that widespread patterns of correlations 32 
exist in low frequency BOLD signals, which we posit are due to fluctuations in CBF associated with 33 
CA.   34 
2. Methods and Materials 35 
2.1. Experimental Protocol 36 
 4 
2.1.1. Magnetic Resonance Imaging Acquisition 1 
The study consisted of two separate experiments conducted on two different scanners. Nine healthy 2 
volunteers (age 22-37 years) were recruited for a 3T session to collect single-echo fMRI data (3T) and 3 
five additional healthy volunteers (age 30-41 years) were recruited for a 7T session to collect multi-4 
echo fMRI data (7T-ME). All participants gave written informed consent, and the School of 5 
Psychology Cardiff University Ethics Committee approved the study in accordance with the guidelines 6 
stated in the Cardiff University Research Framework (version 4.0, 2010). 7 
The 7T scan protocol was added to enable us to address the origin of MAP correlated fMRI signal 8 
changes. Primarily this was achieved by using a multi-echo acquisition, which allows us to separate 9 
the pure BOLD component from the fMRI signal. Furthermore, the session consisted of two scans 10 
with differing acquisition parameters (see section 2.2.2 below for theoretical details).  11 
3T 12 
Two twenty-minute rs-fMRI runs were acquired on a 3T GE HDx scanner (GE Healthcare, Milwaukee, 13 
WI, USA) with an eight-channel receive head-coil using a gradient-echo EPI readout with a single 14 
echo time (TR=2000ms; TE=35ms; flip angle (α)=90°;	FOV=224mm; 3.5 mm2 in-plane resolution; 33 15 
slices (3.5 mm + 0.5mm gap), SENSE (GE ASSET) acceleration factor=2). Whole-brain T1-weighted 16 
anatomical images were acquired using an FSPGR sequence (FOV=256mm, TR=7900ms, TE=3ms, 17 
172 contiguous sagittal slices,1mm3 isotropic). 18 
7T-ME 19 
Two ten-minute eyes-closed rs-fMRI runs were acquired on a 7T Siemens MAGNETOM scanner 20 
(Siemens Healthcare GmbH, Erlangen, Germany) equipped with a single-channel transmit/32-21 
channel receive head coil (Nova Medical, Wilmington, MA, USA). The CMRR SMS-EPI sequence 22 
(R015) (Moeller et al., 2010) was used to acquire multi-echo multiband EPI data with three echoes 23 
using the following parameters: Scan 1 – (TR=1000ms; TE1/2/3=8.14/21.47/34.8ms; flip angle (α)=35°; 24 
FOV=220 mm; 2.4mm2 in-plane resolution; 36 slices (2.5 mm thick); multiband factor=4; GRAPPA 25 
acceleration factor=2) and Scan 2 – (TR=500ms; TE1/2/3=8.14/21.47/34.8ms; flip angle (α)=90°; 26 
FOV=220 mm; 2.4mm2 in-plane resolution; 6 slices (2.5 mm thick); multiband factor=1; GRAPPA 27 
acceleration factor=2). Whole brain T1-weighted anatomical images were acquired using an MPRAGE 28 
sequence (FOV=220mm, TR=2200ms, TE=3ms, TI=1050ms, 224 contiguous sagittal slices, 0.7 mm3 29 
isotropic).  30 
2.1.2. Physiological monitoring 31 
Concurrent physiological traces were recorded for all runs and sampled at 500Hz (CED, Cambridge, 32 
UK). This included using photoplethysmography (PPG) to measure pulse waveforms for deriving 33 
cardiac information, a pneumatic respiratory belt for timing and relative respiration volume measures, 34 
capnography for measuring expired partial pressure of end-tidal carbon dioxide (PETCO2). The 35 
CareTaker system (Biopac) was used to measure beat-to-beat blood pressure with a cuff attached to 36 
 5 
the first digit of the hand (thumb). The system uses the cuff to pneumatically sensor the arterial 1 
pressure wave, and estimates beat-to-beat systolic and diastolic blood pressure via analysis of the 2 
timing between different components of the pulse waveform (Baruch et al., 2011), and has been 3 
validated against gold standard arterial line measurements (Baruch et al., 2014).   4 
2.2. Data Analysis 5 
2.2.1. Preprocessing 6 
Data were preprocessed and registered to a standard space using a pipeline created with AFNI, FSL 7 
and in-house code. Preprocessing of 3T and 7T-ME data consisted of the same following steps: 1) 8 
De-spiking; 2) Motion correction by registering all volumes to the first one. For 7T-ME scans steps 1-2 9 
were performed separately for each echo time dataset, then a nonlinear fit was performed to create S0 10 
and R2* datasets (see section 2.2.2 below). Subsequent steps were performed separately for S0 and 11 
R2* datasets. 3) Nuisance regression with pre-whitening (Bright et al., 2017) to remove cardiac and 12 
respiratory related noise (Birn et al., 2008; Chang et al., 2009; Glover et al., 2000), end-tidal CO2 13 
fluctuations (convolved with HRF), and six estimated motion parameters; 4) Slice time correction; 5) 14 
Non-linear registration to 2mm MNI space; 6) De-trending and motion censoring in a single step, with 15 
the top 5% of volumes most severely corrupted by motion (according to framewise displacement) 16 
being censored. Censored time points were replaced with interpolated values calculated from 17 
neighbouring (non-censored) time points (NTRP option in 3dTproject) in order to keep to the data 18 
temporally consistent for subsequent wavelet decomposition. A discrete wavelet transform was then 19 
performed on the preprocessed data (see section 2.2.3 below). Note that physiological noise 20 
correction was performed on unfiltered data.  21 
For each subject grey matter (GM) masks were created from segmented T1 images, with GM voxels 22 
defined as those with a partial volume estimate greater than 66%. GM masks were used in 23 
subsequent parts of the analysis, and GM mask averaged time series were calculated for 3T and 7T-24 
ME data for estimating the global lag with blood pressure (see section 2.2.4 below).  25 
2.2.2. Multi-echo fit 26 
Assuming a mono-exponential decay, the signal across multiple echo times can be described 27 
according to equation 1. 28 
𝑆 𝑇𝐸 = 𝑆!𝑒!!!∗!" 
Equation 1 29 
Where S0 is spin density weighted signal intensity at zero echo time and R2* is the apparent 30 
transverse relaxation rate (inverse of relaxation time T2*). S0 is modulated by changes in apparent T1 31 
(e.g. due to inflow) and bulk motion and related spin history effects, whereas R2* reflects magnetic 32 
field homogeneity and thus, due to blood oxygenation induced changes in microscopic susceptibility, 33 
 6 
the source of the BOLD effect (Buxton, 2013). NVC related functional responses in gradient-echo 1 
fMRI are considered to be driven almost entirely by R2* changes, which has motivated the use of 2 
multi-echo acquisitions for separating neuronal from non-neuronal signal components (Kundu et al., 3 
2017; Posse, 2012), based on the rationale that non-neuronal components (i.e. not flow related) are 4 
mostly restricted to changes in S0. It should be noted that inflow effects on S0 are driven by changes 5 
in flow velocity through an imaging slice, and so may partially reflect changes in CBF, however this 6 
effect is generally considered to be small in multi-slice acquisitions with standard TRs (Gao and Liu, 7 
2012).  8 
However, as discussed above, there are non-neuronal contributors to flow, whose activity in principle 9 
should manifest primarily in the form of R2* changes. Ignoring the effects of macroscopic field 10 
inhomogeneity, more generally R2* changes are driven by CBF dynamics (via the changes in blood 11 
oxygenation they produce), whether they are neuronally driven or not. The motivation for collecting 12 
7T-ME data as part of this study is that it allows us to determine to what extent MAP-fMRI correlations 13 
are driven by changes in R2* and S0, and thus whether or not they are related to changes in CBF. 14 
Moreover, as S0 is determined by the steady-state longitudinal magnetization it is intrinsically 15 
dependent on acquisition parameters like TR and flip angle. Thus, any significant S0 fluctuations are 16 
likely to be modulated between 7T-ME scans 1 and 2, whereas R2* fluctuations will not.  17 
For each voxel and TR, 7T-ME data were fit to the mono-exponential signal model with a nonlinear 18 
least-squares approach using the Levenberg-Marquardt algorithm (Galassi, 2009), creating S0 and R2* 19 
datasets. In multi-echo fMRI studies numerous physical limitations restrict the number of echo times 20 
that can be achieved to a small number, in this case three, which presents a challenge for accurate 21 
estimation of relaxation rates (Gowland and Bowtell, 2007), and sample-by-sample parameter 22 
estimates are considered to be noisy (Kundu et al., 2012) . Compared with previous studies, here we 23 
benefit from the higher SNR afforded by 7T to improve sample-by-sample parameter estimates, and 24 
we performed simulations to better understand the precision with which R2* and S0 can be measured 25 
using our nonlinear fit approach (details included in Supplementary material). These simulations 26 
demonstrate that across the expected range of R2* values, our choice of echo times allows us to 27 
estimate both R2* and S0 parameters without bias.  28 
2.2.3. Maximum overlap discrete wavelet transform 29 
Wavelet transforms provide a way of decomposing the total variance within a time series into different 30 
frequency scales (see (Bullmore et al., 2004) for an fMRI focused review). They are conceptually 31 
similar to Fourier transforms, but because wavelets are compactly supported (i.e. transient, not 32 
extending infinitely like sine waves), they provide sensitivity to non-stationary features within the 33 
scales of the decomposition. Thus, wavelet coefficients (WC) provide a “time-frequency” 34 
representation of data, including both temporal and spectral information, analogous to moving-window 35 
Fourier transforms. This makes the discrete wavelet transform useful for analysing real-world 36 
physiological data, which are expected to be non-stationary, and the multi-resolution analysis allows 37 
signal energy to be decomposed into distinct frequency bands. Given that fluctuations in MAP are 38 
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expected to show more power in certain frequency bands, likely reflecting different underlying 1 
mechanisms, in this study we used a wavelet transform to identify the frequency scale of interest for 2 
the relationship between MAP and fMRI signals.  3 
For each voxel time series the maximum overlap discrete wavelet transform (MODWT) was used to 4 
decompose the signal into 6 scales (Witcher, 2015). The MODWT used a fourth-order Daubechies 5 
wavelet filter as has been used previously for fMRI applications (Bullmore et al., 2001; Patel and 6 
Bullmore, 2016). The central frequency () and band between lowest () and highest () frequencies 7 
contained within each scale () depends on the sampling rate (), and is given by equations 2 and 3 8 
𝑓!"# −  𝑓!!"! =  12 !!! 𝑇𝑅 − 12!𝑇𝑅 
Equation 2 
𝑓! =  𝑓!"# +  𝑓!!"!2  
Equation 3 
 
In summary, each fMRI time series consisting of N volumes was decomposed into 6 frequency 9 
scales, each composed of N WCs. For reference the scale frequency bands for the TRs used in this 10 
study are given in table 1 and the frequency response of the filters at each scale are shown in 11 
Supplementary Fig. 1.  12 
<insert Table 1> 13 
2.2.4. Blood pressure correlation 14 
Beat-to-beat systolic (SBP) and diastolic (DBP) blood pressure time series were processed in-house 15 
with a robust outlier removal procedure and resampled to the relevant TR. Mean arterial pressure 16 
(MAP) was estimated according to equation 4 (Brzezinski, 1990) 17 
𝑀𝐴𝑃 =  23 𝐷𝐵𝑃 +  13  𝑆𝐵𝑃  
Equation 4 18 
 
MAP time series were decomposed with a MODWT into the same 6 frequency scales as the fMRI 19 
data. Fig. 1 shows a MAP time series and its WCs for a representative subject. For each run the 20 
cross-correlation between the average grey matter signal and temporally displaced MAP signals was 21 
calculated. The raw cross-correlation functions were then fit to a set of Legendre polynomial functions 22 
of increasing order (until R2 > 0.95, or up to a maximum order of 10) to obtain a smooth function from 23 
which the lag between MAP and fMRI fluctuations was obtained. Voxelwise correlations between 24 
 8 
MAP and scale matched fMRI WCs for all frequency scales were calculated with the globally 1 
optimised lag. Additionally, although more susceptible to noise, we calculated a voxelwise lag using 2 
the same procedure and then calculated corresponding correlations between MAP and scale matched 3 
fMRI WCs.  4 
<insert Figure 1> 5 
 6 
It should be noted that in contrast with the discrete wavelet transform (DWT), which is orthogonal (like 7 
the discrete Fourier transform), the MODWT is an oversampled transform in which there is some 8 
redundancy (i.e. coefficients are not completely independent). This means that the effective degrees 9 
of freedom are reduced, which impacts on statistical parameters. Additionally, the practice of filtering 10 
time series and allowing temporal shifts changes the null distribution of Pearson’s correlations (Bright 11 
et al., 2017). To address these potential confounds on statistical inference we performed a 12 
permutation analysis to determine the correct null hypothesis. The approach, which has been used 13 
previously (Bright et al., 2017), estimates the null distribution with phase-randomised versions of the 14 
MAP time series. For each subject 1000 phase-randomised MAP traces were correlated with fMRI to 15 
get a voxel-wise estimate of the correlation null distribution from which p-values were calculated.  16 
2.2.5. Group level analysis 17 
For each frequency scale, subject level MAP - fMRI WC correlation maps were entered into an 18 
independent two-tailed t-test, from which group-level correlation and Z-score maps were derived. The 19 
mean GM correlation and Z-score values were calculated as a means of identifying the scale with the 20 
strongest MAP vs. fMRI coupling. Subsequent analyses of 7T-ME data are restricted to the scale with 21 
the matched frequency. Test–retest repeatability was assessed using spatial correlation between 22 
Scan 1 and Scan 2 for 3T. For 7T-ME data, Scan 2 parameters were chosen differently from Scan 1 23 
from a theoretical perspective to maximise any potential inflow effect in the S0 signal (Gao and Liu, 24 
2012). For the different sources of image contrast, R2* and S0, to assess their relative contributions to 25 
MAP – fMRI correlations, the absolute value of average GM vs. MAP correlations were entered into a 26 
two way repeated measures ANOVA.  27 
Note, that although a wavelet transform was used to decompose MAP and fMRI signals into different 28 
frequency scales, we also looked at the effect of MAP on unfiltered data by regressing unfiltered 29 
optimal lag MAP traces onto voxel-wise unfiltered fMRI data (see Supplementary Fig. 4).  30 
3. Results 31 
3.1. 3T 32 
3.1.1. Global lag 33 
 9 
Fig 1A, shows an example taken from a representative subject of GM and MAP traces, and their 1 
respective WCs at the 6 frequency scales listed in Table 1. Fig.1B shows the group mean cross-2 
correlation functions between MAP and GM WC time series for each scale of the MODWT. Scales 1-3 3 
all show clear maxima with a similar degree of lag (5.75, 5.50, and 5.25 seconds for scales 1-3 4 
respectively).  5 
3.1.2. MAP vs. fMRI correlation 6 
Voxelwise group average correlations (at optimal lag) are shown for scale 2 WCs only in Fig. 2C, 7 
along with corresponding Z-scores in Fig. 2D. Fig. 2A shows the mean correlation values and Z-8 
scores within the voxelwise group maps for all scales (at optimal lag), and it can be seen the scale 2 9 
has the highest mean correlation value and highest mean Z-score value. It can be seen by the 10 
standard deviation error bars that the majority of voxels at scale 2 have a Z-score > 3.1 (p = 0.001). 11 
Fig. 2B demonstrates that the spatial correlation between scans (i.e. within subject agreement) is also 12 
highest for scale 2 compared with the other scales. As documented in Table 1, the frequency band for 13 
scale 2 for 3TSE data (TR=2s) is 0.063 – 0.125 Hz, which corresponds to a central frequency () of ~ 14 
0.1 Hz. 15 
<insert Figure 2> 16 
As stated in section 2.2.3, permutation tests based on phase-randomised MAP time series were used 17 
to estimate the correlation null distribution for each subject on a voxel-wise basis. Supplementary 18 
Figure 3A shows the correlation null distributions estimated for each subject, and the mean GM 19 
correlation value. For each subject the null distribution is non-zero, as expected due to the effect of 20 
temporal shifting, but in every case the true mean GM correlation with MAP is more than 3 standard 21 
deviations removed from the null correlation. Supplementary Fig. 2B shows subject level correlation 22 
maps along with associated threshold permutation test p-values.  23 
For reference, Supplementary Fig. 4 shows the estimated effect size of unfiltered MAP fluctuations on 24 
fMRI data. The average GM effect size across subjects (±SD) is 0.01 %BOLD/mm Hg (±0.006). 25 
Across subjects the average absolute maximum deviation in MAP is ~ 12 mm Hg, which suggests 26 
fairly modest total BOLD signal changes on the order of ~0.12% are expected, but given the 27 
heterogeneity evident in Supplementary Fig. 4, it is clear that in some regions this may be as large as 28 
~0.5%.   29 
3.1.3. Voxelwise lag 30 
Fig. 3A shows group level MAP - fMRI correlations as a function of lag with respect to MAP. It shows 31 
how a spatially structured pattern of fMRI signal changes evolves over time in response to MAP 32 
fluctuations. Fig. 3B/C shows the maximum correlation and the lag at which it is seen respectively. 33 
The lag time in cortical grey matter appears relatively uniformly distributed at ~ 5 s, in good 34 
agreement with the GM signal global lags shown in Fig. 1. Interestingly, there is a correlation pattern 35 
that emerges earlier (~ 2-4 s), which appears in deep white matter structures and in the areas 36 
 10 
bordering the lateral ventricles. Fig. 3B shows that there are widespread correlations with MAP, albeit 1 
with different lags, extending across the whole brain. 2 
<insert Figure 3> 3 
3.2. 7T 4 
The 7T-ME data allows us to tease apart the different sources of contrast underlying the MAP - fMRI 5 
correlations. Fig. 4A shows group level voxelwise MAP - R2* and MAP - S0 correlations for Scan 1 6 
and Scan 2. R2* - MAP correlations show a similar pattern to 3T fMRI – MAP correlations, with well 7 
defined grey/white matter contrast and matching areas of high magnitude correlations (e.g. in occipital 8 
cortex). Note that negative R2* - MAP correlations are equivalent to positive MAP – fMRI (3T) 9 
correlations, as a decrease in R2* corresponds to a lengthening of T2* and a positive increase in 10 
BOLD signal. Fig. 4B shows the spatial correlations between R2* - MAP and S0 – MAP correlation 11 
maps, and 3T BOLD – MAP correlation maps. Compared with S0 – MAP correlations, R2* - MAP 12 
correlation maps are more spatially similar to 3T BOLD – MAP correlation maps, with a Pearson’s 13 
correlation of -0.68 vs 0.33 of S0 – MAP, which amounts to ~4 times as much variance explained. 14 
Note that the negative correlation in Fig. 4B i) is due to the inverse relationship between R2* and the 15 
BOLD signal (a BOLD signal increase results from less dephasing, i.e a decrease in relaxation rate). 16 
Fig. 4C shows the group mean GM absolute correlation values for R2* and S0 scans 1 and 2.  A two-17 
way repeated measures ANOVA revealed a significant effect of contrast (R2* > S0), but no effect of 18 
scan. Following the rationale outlined in section 2.2.2, this would suggest that the MAP correlated 19 
fMRI signal has a BOLD origin related to changes in CBF. Furthermore, there appears to be minimal 20 
non-BOLD contribution, as scan number did not significantly modulate the MAP-S0 correlation values.  21 
4. Discussion 22 
4.1. Blood pressure correlation 23 
To our knowledge, this study is first to demonstrate that MAP LFOs are positively correlated with fMRI 24 
LFOs within the frequency band between 0.063 and 0.125 Hz. These correlations appear highly 25 
spatially structured, with strong grey/white matter contrast, and are repeatable between subjects with 26 
a spatial correlation of ~ 0.42. Results from the 7T-ME data suggest that fluctuations in MAP lead to 27 
grey matter signal fluctuations in BOLD fMRI that are primarily related to CBF, given that they are 28 
related to changes in R2* and relatively independent of acquisition parameters. This is consistent with 29 
a large TCD literature that shows beat-to-beat fluctuations in blood pressure result in measurable 30 
changes in CBFV in large intracranial arteries (Aaslid et al., 1989; Blaber et al., 1997; Diehl et al., 31 
1991; Kuo et al., 1998; Zhang et al., 1998). The same studies also make it clear that there is a lag in 32 
CBFV fluctuations with respect to MAP (i.e. the CBFV response occurs later), which has been 33 
 11 
estimated at ~ 2 s (Kuo et al., 1998). The delay time ~5.5 s estimated from these data is markedly 1 
longer, but this is perhaps not surprising given that BOLD fMRI is sensitive to flow in a different 2 
vascular compartment (i.e. deoxygenated/venous blood flow). An increased lag time would be 3 
expected to account for the fact the flow changes will take time to propagate along the vascular tree. 4 
Delayed fMRI responses to hypercapnia challenges are frequently observed on the order of 8 – 15 5 
seconds (Blockley et al., 2011; Murphy et al., 2011), although potentially longer in patient groups 6 
(Donahue et al., 2016; Duffin et al., 2015), and are presumed to contain both gas bolus transit time 7 
and vascular reactivity information. Further research into the causal relationship underlying MAP 8 
correlated fMRI signals is needed in order to better interpret what this delay time reflects.  9 
 Somewhat more difficult to explain is the apparent shorter lag time in white matter, in particular 10 
bordering the ventricles, as seen in the voxel-wise lag time in Fig 3. Assuming a purely flow based 11 
explanation, one would expect a longer delay time in white matter, as blood arrival time is extended 12 
compared to grey matter (van Gelderen et al., 2008). However, this finding is consistent with the anti-13 
correlated signal changes observed during in the same areas during respiratory challenges (Bright et 14 
al., 2014). It suggests that in regions located at the edge of CSF spaces, signal changes may be 15 
dominated by fluctuations in CSF partial volume as opposed to flow related (BOLD) changes. This 16 
interpretation is supported by Fig.3A, in which it can be seen that that the earliest signal changes 17 
occur in the regions proximal to the ventricles. This is expected according to the Monroe-Kellie 18 
doctrine, i.e. within a rigid skull volume changes in different fluid compartments must be balanced. 19 
Thus, it is possible that changes in arterial blood volume preceding the BOLD signal change are 20 
associated with matched changes in CSF volume, although this is only speculative and requires 21 
further evidence.  22 
From these data we cannot know the exact origin of these BP correlated fMRI fluctuations. Previous 23 
fMRI studies have found signal fluctuations that are correlated with peripheral measures of vascular 24 
tone, such as NIRS in fingers/toes (Tong and Frederick, 2010; Tong et al., 2012; Tong et al., 2013) or 25 
amplitude of photoplethysmography (PPG) (Ozbay et al., 2018; van Houdt et al., 2010). These 26 
observations support the existence of endogenous systemic LFOs, which propagate throughout the 27 
entire cardiovascular system, appearing as synchronized, but out of phase, oscillations at different 28 
vascular sites. A common systemic source is one explanation for the MAP correlated fMRI signals we 29 
have measured, and a potential candidate for this systemic origin is sympathetic nervous activity 30 
(SNA). The MODWT reveals that MAP coupled fMRI LFOs are strongest in the frequency band 31 
centred at ~ 0.1 Hz, the frequency of Mayer waves, which are defined in terms of their coherence with 32 
SNA (Julien, 2006). SNA regulates blood pressure via modulation of peripheral vascular tone (Fisher 33 
and Paton, 2012), but also potentially influences cerebrovascular tone (Brassard et al., 2017), and 34 
increases in SNA elicited by post exercise induced ischemia have been shown to decrease 35 
compliance in the brain’s major arteries (Warnert et al., 2016). Orthostatic challenges such as lower 36 
body negative pressure (LBNP), which are associated with increases in SNA, lead to considerable 37 
reductions in MCA CBFV (Levine et al., 1994; Serrador et al., 2000; Zhang and Levine, 2007), and 38 
reductions in blood volume indicative of vasoconstriction in the brain’s largest arteries (Whittaker et 39 
 12 
al., 2017). Furthermore, studies have shown that ganglion blockade designed to dampen SNA, 1 
significantly alter the dynamics between MAP and CBFV (Mitsis et al., 2009; Zhang et al., 2002), 2 
suggesting autonomic neural control cerebrovascular tone likely plays a role in beat-to-beat CBF 3 
regulation.  4 
4.2. Cerebral autoregulation 5 
The time scale of the BP correlated LFO and its basis predominantly being changes in apparent 6 
transverse relaxation is strongly indicative of a CBF related cause. Compared with respiratory 7 
challenges for which the CBF response primarily probes CVR, the observed flow response associated 8 
with BP is likely to be related to the process of CA. Thus, whereas CVR is a measure of localized 9 
vascular integrity, i.e. the ability of arterial vessels to change their resistance, measures of CA relate 10 
to the systemic orchestrated vascular mechanisms that regulate CBF (Carrera et al., 2009). The LFO 11 
fluctuations we have observed in this study are correlated with BP measured in the periphery, and so 12 
are more related to CA than CVR. Impairments in CA associated with adverse cerebrovascular events 13 
such as ischaemic stroke and severe head injury have been well studied (Panerai, 2008), and are 14 
increasingly thought to play a role in the development of vascular dementia (Toth et al., 2017) and 15 
Alzheimer’s disease (Claassen and Zhang, 2011; den Abeelen et al., 2014). Despite the widespread 16 
clinical implications of pathological CA, its underlying mechanisms are still relatively poorly 17 
understood.  18 
TCD is the most widely used modality for measuring CA, which despite having excellent temporal 19 
resolution and high suitability for clinical settings, is ultimately of limited value since the 20 
measurements are restricted to only the largest intracranial arteries. In contrast, fMRI has whole-brain 21 
sensitivity with millimeter resolution and so is a desirable tool for better understanding CA, and has 22 
the potential to deliver more predictive clinical measures. For example, CA is critical for keeping 23 
stable CBF in the penumbra region following ischaemic stroke (Xiong et al., 2017), so a method such 24 
as fMRI, which has the spatial resolution to resolve localized alterations, is promising as a more 25 
informative prognostic tool. In the TCD literature the transfer function between BP and CBFV is used 26 
to characterize CA, primarily through gain and phase shift. It is commonly assumed that a phase shift 27 
and low gain constitutes good cerebral autoregulation (i.e. CBFV fluctuations are delayed with respect 28 
to BP and are dampened) (van Beek et al., 2008). In this study we observed a lag in fMRI with 29 
respect to MAP, which may be related to the phase shifts measured in TCD. Furthermore, although 30 
the effect-size of MAP on fMRI measured here appears small (Supplementary Fig. 4), this may be 31 
due to the young healthy subject group. In patient groups with less effective CA both effect-size and 32 
lag may be modulated. 33 
4.3. Effect on resting-state fMRI 34 
This study provides the first step in characterising the relationship between MAP and the fMRI signal, 35 
but further work is needed to address the degree to which MAP impacts functional connectivity 36 
 13 
measures. The estimated effect size on unfiltered data is relatively modest (~0.01 %BOLD/mm Hg), 1 
which across subjects on average amounts to total BOLD signal changes on the order of ~0.1% 2 
across all grey matter, although total signal changes as large ~0.5% are possible, depending on 3 
individual subject response variability. The results of the wavelet transformed data show that MAP 4 
fluctuations effect fMRI within a particular frequency band, and as in practice resting-state fMRI 5 
analyses never use raw unfiltered data, it is likely that the effect of MAP on functional connectivity 6 
metrics will depend on a variety of analysis choices, such as filter passband or window length in 7 
dynamic connectivity studies. These data also serve as a reminder that not all sources of BOLD 8 
contrast are neuronal in origin, and so multi-echo based approaches like ME-ICA (Kundu et al., 2012) 9 
are likely to be less effective. An interesting avenue of future research would be look at the effect of 10 
different echo combination and de-noising schemes to determine their impact.  11 
4.4. Conclusion 12 
In this study we have shown that beat-to-beat fluctuations in BP are correlated with fluctuations in the 13 
resting-state fMRI signal that are delayed by approximately 5.5 seconds, and which are strongest at 14 
the frequency band centered at ~0.1 Hz. Using a multi-echo acquisition we were able to isolate the 15 
pure BOLD (R2*) component of the BP correlated fMRI signal and have shown that it is the main 16 
source of contrast. This would indicate that it is changes in CBF that mediate this low frequency BP 17 
correlated signal, which we hypothesize is related to the process of CA. We propose that resting-state 18 
fMRI is a promising new tool for assessment of dynamic CA with high spatial resolution, which may 19 
prove to be a useful biomarker in a range of cerebrovascular and neurological conditions.  20 
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Tables 17 
Scale 
TR (s) 
2 1 0.5 
1 0.125 - 0.250 0.250 - 0.500 0.500 1.000 
2 0.063 - 0.125 0.125 - 0.250 0.250 - 0.500 
3 0.031 - 0.063 0.063 - 0.125 0.125 - 0.250 
4 0.016 - 0.031 0.031 - 0.063 0.063 - 0.125 
5 0.008 - 0.016 0.016 - 0.031 0.031 - 0.063 
6 0.004 - 0.008 0.008 - 0.016 0.016 - 0.031 
Table 1: Table showing the frequency range (Hz) for each scale of the MODWT. 18 
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Figure captions 20 
 21 
Figure 1: A i) Shows the mean grey matter signal from 3TSE data in a representative subject along with 22 
corresponding mean arterial pressure trace (ii). Wavelet coefficients at 6 scales are shown for both GM 23 
 18 
and MAP. B) Group mean cross-correlation function between MAP and GM for each scale, with shaded 1 
area representing SEM.  2 
 3 
Figure 2: 3TSE data. A) Mean correlations and Z-scores (across voxels) from group mean statistical 4 
parameter maps for each scale. Dotted lines indicated the p-value for give z-score vales. B) Spatial 5 
correlation scans 1 and 2  MAP-fMRI correlation maps for each scale. C) Group mean MAP – fMRI 6 
correlation map for scale 2 WC and corresponding Z-scores (D). Correlations are those at the optimal lag 7 
values as shown in Fig. 1.  8 
 9 
Figure 3: 3TSE data. A) MAP – fMRI as a function of lag with respect to MAP, in 2 second intervals. B) The 10 
maximum correlation (i.e. arg max of cross-correlation function) and the associated lag time (C).  11 
 12 
Figure 4: 7TME data. A) group level MAP – fMRI correlation maps for R2* and S0 and scans 1 and 2, at the 13 
frequency scale corresponding to 0.063 – 0.125 Hz (scales 3 and 4 for scans 1 and 2 respectively). B) 14 
Spatial correlation between 7TME MAP – R2*/S0 correlation maps, and 3TSE MAP – fMRI correlation 15 
maps. C) Bar chart showing group mean GM correlations (absolute value) for R2*/S0 and scans 1 and 2.  16 
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